In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

For AmeriNet, A New Way to Work With Suppliers

Executive Summary

For years, virtually alone among the leading hospital groups, AmeriNet Inc. has preserved an almost sacred neutrality when it comes to product suppliers. AmeriNet has focused on dual-source contracts with branded suppliers. Promoting the merits of choice, voice, and value, the group has built supplier relationships almost exclusively through its contracting arm, careful always to make certain that its diverse hospital and alternate-site membership had access through its contracts to the leading brand name suppliers. But now, AmeriNet is venturing beyond these kinds of programs into a new form of supplier relationship. AmeriNet has agreed to work with Masimo Corp. which has been a long-timer supplier of OEM products to other device companies, to promote an innovative new pulse oximetry technology to AmeriNet members and supply partners.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV001406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel